Page last updated: 2024-09-03

5-amino-2,4-dihydroxy-alpha-methylphenylethylamine and ibutamoren mesylate

5-amino-2,4-dihydroxy-alpha-methylphenylethylamine has been researched along with ibutamoren mesylate in 1 studies

Compound Research Comparison

Studies
(5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
Trials
(5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
Recent Studies (post-2010)
(5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
Studies
(ibutamoren mesylate)
Trials
(ibutamoren mesylate)
Recent Studies (post-2010) (ibutamoren mesylate)
10001021914

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bailey, AR; Dickson, SL; Leng, G; Smith, RG; von Engelhardt, N; Von Englehardt, N1

Other Studies

1 other study(ies) available for 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine and ibutamoren mesylate

ArticleYear
Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway.
    Journal of neuroendocrinology, 2000, Volume: 12, Issue:3

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Brain Stem; Growth Hormone; Growth Hormone-Releasing Hormone; Indoles; Male; Neurotoxins; Oligopeptides; Phenethylamines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spiro Compounds; Tyrosine 3-Monooxygenase

2000